<DOC>
	<DOCNO>NCT02094963</DOCNO>
	<brief_summary>The purpose study assess safety efficacy Ticagrelor versus Clopidogrel Asian/KOREAn patient acute coronary syndrome intend invasive management .</brief_summary>
	<brief_title>Safety Efficacy Ticagrelor Versus Clopidogrel Asian/KOREAn Patients With Acute Coronary Syndromes Intended Invasive Management</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Age 18 Index event nonST ST segment elevation ACS Provision sign informed consent Hypersensitivity aspirin ticagrelor Oral anticoagulation therapy stop Treated thrombolysis within 24hrs Any reason investigator deems subject unsuitable study e.g. , Active malignant tumor Concomitant therapy strong CYP3A inhibitor , CYP3A substrates narrow therapeutic index , strong CYP3A inducer Any lifethreatening condition life expectancy le 6months Mental condition ( dementia , alcohol drug abuse ) may affect study compliance prevent understand aim , investigational procedure possible consequence study High risk due malignant hypertension The condition associate increase risk bradycardiac event Subjects severe liver disease Subjects require dialysis Increased bleed risk History cerebral hemorrhage , gastrointestinal bleeding within 6months , major surgical procedure within 30days Thrombocytopenia leukopenia Positive pregnancy test know pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>acute coronary syndrome</keyword>
	<keyword>coronary disease</keyword>
	<keyword>coronary artery disease</keyword>
</DOC>